USPTO serial 79330277
GP GETEIN BIOTECH, INC.
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 22, 2023
- Examiner
- KLUWE, CHERYL D
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GP GETEIN BIOTECH, INC.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy T. Wang
Timothy T. Wang NI, WANG & MASSAND, PLLC8140 Walnut Hill Lane, Suite 615Dallas, TX 75231UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes, namely, medicines for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; biological preparations for medical purposes, namely, preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; diagnostic preparations for medical purposes; biochemical preparations for medical use, namely, preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Medicated serums for treatment of viral infections, diseases of the blood system, diseases of the immune system, skin diseases, diseases caused by bacterial exotoxins, bacterial infections, fungal infections, parasitic infections; chemical preparations for medical purposes, namely, for cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Drugs for medical purposes for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Pharmaceutical preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; vaccines; dietetic substances adapted for medical use | ACTIVE | — |
| 010 | Diagnostic testing apparatus for testing blood sugar levels, cancer cells, DNA, sugars, hormones, enzymes, lipids, vitamins, inorganic ions, electrolytes, drugs and drug metabolites, autoantibodies, proteins, microorganisms, Drug allergy, allergens, antigens of pathogenic pathogens, antibodies of pathogenic pathogens and nucleic acids of pathogenic pathogens, blood type, tissue type, human genes, hereditary diseases, biochemical indicators, immune function indicators, narcotics, psychotropic drugs, Toxic drugs for medical use, therapeutic drug targets, tumor markers for medical purposes; diagnostic apparatus for use in medical analysis of blood; surgical apparatus and instruments; blood testing apparatus; galvanic therapeutic appliances for wound healing; Diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells, DNA, sugars, hormones, enzymes, lipids, vitamins, inorganic ions, electrolytes, drugs and drug metabolites, autoantibodies, proteins, microorganisms, Drug allergy, allergens, antigens of pathogenic pathogens, antibodies of pathogenic pathogens and nucleic acids of pathogenic pathogens, blood type, tissue type, human genes, hereditary diseases, biochemical indicators, immune function indicators, narcotics, psychotropic drugs, Toxic drugs for medical use, therapeutic drug targets, tumor markers; Medical apparatus and instruments, namely, for cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases diagnosis; urological apparatus and instruments for surgery, diagnostic testing, treatment, adjuvant therapy; X-ray apparatus for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Getein Biotech, Inc.
- Other trademarks owned by Getein Biotech, Inc.
- Other trademarks owned by Getein Biotech, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named GP GETEIN BIOTECH, INC.
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 11, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 22, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 22, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 22, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 22, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 22, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 26, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 7, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 7, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 6, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 6, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 6, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 17, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 17, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 17, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 4, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 4, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 4, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 4, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 4, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 27, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 27, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 21, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 3, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 3, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 10, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 9, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 11, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 7, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 6, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |